Further, miR-1246 was higher expressed in the more aggressive molecular breast cancer subtypes (Basal, Her2+, Luminal B) compared to the less aggressive Luminal A subtype (Figure 1D). This evidence concerns the gene ERBB2 and breast carcinoma.